Product image of Levetiracetam Normon (Levetiracetam) supplied by GNH India

Levetiracetam Normon

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Normon (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Normon, is an antiepileptic presented as an intravenous solution for intravenous use. It is indicated for the treatment of partial‑onset seizures and generalized seizures in patients with epilepsy.

GNH India supplies Levetiracetam Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Laboratorios Normon, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic drug that modulates neuronal excitability in seizure disorders.
  • Partial‑onset seizures: reduces the frequency and severity of focal seizures.
  • Generalized seizures: helps control tonic‑clonic and other generalized seizure types.
  • Adjunct therapy for epilepsy: used in combination with other antiepileptic agents when monotherapy is insufficient.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic transmission and stabilises neuronal firing, thereby decreasing the likelihood of abnormal electrical activity that precipitates seizures.

Side Effects

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Fatigue: feeling unusually tired or weak.
  • Headache: mild to moderate head pain.
  • Irritability: mood changes or increased agitation.
  • Nausea: occasional stomach upset.
  • Nasal congestion: mild upper‑respiratory irritation.

Serious or Rare Side Effects

  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Mood disorders: depression, suicidal thoughts, or aggressive behaviour.
  • Hematologic abnormalities: low white blood cell or platelet counts.
  • Hepatic dysfunction: elevated liver enzymes.
  • Respiratory depression: rare but potentially life‑threatening breathing difficulty.
  • Anaphylaxis: acute allergic reaction requiring immediate medical attention.

Precautions & Warnings

  • Before initiating therapy, clinicians should assess patient history and monitor for specific concerns.
  • Renal impairment: adjust dosing in patients with reduced kidney function.
  • Psychiatric history: monitor for mood changes or suicidal ideation.
  • Concomitant CNS depressants: use caution when combined with other sedatives.
  • Pregnancy and lactation: evaluate risk‑benefit as safety data are limited.
  • Drug‑specific monitoring: periodic assessment of liver function and blood counts may be warranted.
  • Store below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Levetiracetam can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels.
  • Phenobarbital: can lower levetiracetam exposure.
  • Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely)

  • Sedative agents (e.g., benzodiazepines): may enhance CNS depression.
  • Antidepressants (e.g., SSRIs): watch for increased behavioral changes.
  • Immunosuppressants (e.g., cyclosporine): monitor for altered drug levels.

Frequently Asked Questions

Levetiracetam Normon is an intravenous antiepileptic medication used to treat partial‑onset seizures and generalized seizures in patients with epilepsy. It may be employed as monotherapy or as part of combination therapy when seizure control requires additional agents.

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. By modulating this protein, the drug stabilises neuronal firing and reduces the excessive electrical activity that leads to seizures.

The dosage of levetiracetam is determined by the prescribing clinician based on the patient’s age, weight, renal function, and clinical response. The prescriber will set the appropriate infusion rate and total daily amount.

Safety data for levetiracetam in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and discuss options with the patient before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Levetiracetam has a distinct mechanism targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as phenobarbital. It is generally well tolerated, has fewer drug‑enzyme interactions, and can be used as add‑on therapy without extensive metabolic monitoring.

Levetiracetam Normon should be stored below 25 °C, protected from light and moisture, and kept in its original packaging. Do not freeze the solution, and ensure the container is sealed to maintain sterility until use.

The product is supplied as an intravenous solution and is administered by slow infusion into a vein under aseptic conditions. The infusion rate and total daily dose are set by the treating physician according to the patient’s clinical needs.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, psychiatric effects like depression or suicidal thoughts, hematologic abnormalities, hepatic dysfunction, respiratory depression, and rare anaphylactic reactions. Prompt medical evaluation is required if any of these occur.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid its use. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT